Key Points

• Vaccination coverage among infants subject to the mandatory vaccination requirements in effect since 2018 is high for vaccinations against diphtheria, tetanus, polio, pertussis, Haemophilus influenzae type b, hepatitis B, pneumococcus, and meningococcus C. However, coverage remains insufficient for the measles, mumps, and rubella (MMR) vaccine, with only 87% of infants receiving the second dose. Given the current circulation of the measles virus, only two-dose vaccination coverage of at least 95% is likely to interrupt transmission of the virus.

• 75% of infants born in 2023 received at least one dose of the meningococcal B vaccine, representing an increase of 25.2 percentage points compared to the previous year.

• 28% of infants born in 2023 received at least one dose of the rotavirus vaccine in the region. Significant disparities among departments are observed for this vaccination, which has been recommended since 2023.

• Although meningococcal C vaccination coverage has increased by 4 percentage points among adolescents, catch-up vaccination remains very insufficient among 15- to 19-year-olds, with a coverage rate of 52%.

• 58% of 15-year-old girls and 27% of 15-year-old boys have started their human papillomavirus (HPV) vaccination series. HPV vaccination coverage increased significantly in 2023, with a 13.8-point increase among girls and coverage that nearly doubled among boys compared to 2022. HPV vaccination coverage remains far from the 80% target set in the 10-year cancer control strategy for 2030.

• At the conclusion of the first phase of the HPV vaccination campaign in middle schools, as of December 31, 2023, it is estimated that approximately 61% of girls and 47% of boys aged 12 (born in 2011, mostly enrolled in 7th grade) received at least one dose of this vaccine. These estimates take into account vaccinations administered in middle schools and in the community. A 21-point increase in regional vaccination coverage was observed among girls and a 21-point increase among boys between the start and end of the first phase of the campaign, though it is not yet possible to specify the gain directly attributable to the campaign.

• Vaccination coverage against influenza, COVID-19, and shingles remains insufficient among at-risk individuals. Flu vaccination coverage is declining among people with risk factors, with low coverage among those aged 65–74 (50%). COVID-19 vaccination coverage was 35% among those aged 65 and older. Less than 2% of people aged 65–74 are vaccinated against shingles.